Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Britain Courts Anthropic Amid US Defense Department Dispute 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
PHOENIX and VANCOUVER, British Columbia, June 28, 2017 -- Eternity Healthcare Inc. (OTC:ETAH), announces it has resolved an earlier manufacturing issue affecting 10% of its syringes (nozzles) and resulting in a failure to obtain CE certification and approval. Preliminary testing of a number of nozzles, confirmed compliance with certification standards.
“We are pleased to sort out this final hurdle and look forward to CE auditors completing the inspection process for approval,” said Dr. Salari, President & CEO.
The Lenis® Needle-Free Injection system is comprised of four major components. Currently two of the components have received CE certification and approval and now the third component shall be submitted for approval. We believe the remaining components shall get the approval soon.
Needle-Free Injection System Applications
The Needle-Free Injection system can be used for a vast variety of injectable medications, and supplements. These include injection of Insulin for diabetes, injection of vaccines such as flu vaccine and many others, injection of steroids, vitamins, human growth hormones, infertility medications, a vast number of cancer drugs, cosmetic fillers and a new version of epinephrine drugs such as, Mylan’s Epipen®.
About Eternity Healthcare
Eternity Healthcare or the “Company” (OTC:ETAH) is a medical device company with technologies known as Needle-Free Injection System (the Lenis®). Our products are targeted for use by the healthcare professionals, physicians and consumers directly. For more information on Eternity Healthcare, visit the Company’s website; www.eternityhealthcare.com
Safe Harbor Statement
This release includes forward-looking statements. These statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Company Contact: Dr. Salari President & CEO (604) 324 -1113 [email protected]
